The market for pharmacogenomic testing services is experiencing significant growth, propelled by the rising popularity of personalized medicine and the growing understanding of genetic influences on drug reactions. The increasing demand for precision therapeutics and the broadening utilization in fields such as oncology and psychiatry are contributing to this trend. As a result, the market is expanding rapidly, with revenue expected to increase substantially in the coming years.